Deoxyhypusine Modification of Eukaryotic Translation Initiation Factor 5A (eIF5A) Is Essential for Trypanosoma brucei Growth and for Expression of Polyprolyl-containing Proteins

被引:22
|
作者
Suong Nguyen [1 ]
Leija, Chrisopher [1 ]
Kinch, Lisa [2 ]
Regmi, Sandesh [1 ]
Li, Qiong [1 ]
Grishin, Nick V. [2 ,3 ]
Phillips, Margaret A. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Biophys & Biochem, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
HUMAN AFRICAN TRYPANOSOMIASIS; BLOOD-STREAM FORMS; FACTOR EF-P; SACCHAROMYCES-CEREVISIAE; HYPUSINE MODIFICATION; POLYAMINE METABOLISM; ACTIN CYTOSKELETON; CELL-GROWTH; HOMOLOG; YEAST;
D O I
10.1074/jbc.M115.656785
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The eukaryotic protozoan parasite Trypanosoma brucei is the causative agent of human African trypanosomiasis. Polyamine biosynthesis is essential in T. brucei, and the polyamine spermidine is required for synthesis of a novel cofactor called trypanothione and for deoxyhypusine modification of eukaryotic translation initiation factor 5A (eIF5A). eIF5A promotes translation of proteins containing polyprolyl tracts in mammals and yeast. To evaluate the function of eIF5A in T. brucei, we used RNA interference (RNAi) to knock down eIF5A levels and found that it is essential for T. brucei growth. The RNAi-induced growth defect was complemented by expression of wild-type human eIF5A but not by a Lys-50 mutant that blocks modification by deoxyhypusine. Bioinformatics analysis showed that 15% of the T. brucei proteome contains 3 or more consecutive prolines and that actin-related proteins and cysteine proteases were highly enriched in the group. Steady-state protein levels of representative proteins containing 9 consecutive prolines that are involved in actin assembly (formin and CAP/Srv2p) were significantly reduced by knockdown of eIF5A. Several T. brucei polyprolyl proteins are involved in flagellar assembly. Knockdown of TbeIF5A led to abnormal cell morphologies and detached flagella, suggesting that eIF5A is important for translation of proteins needed for these processes. Potential specialized functions for eIF5A in T. brucei in translation of variable surface glycoproteins were also uncovered. Inhibitors of deoxyhypusination would be expected to cause a pleomorphic effect on multiple cell processes, suggesting that deoxyhypusine/hypusine biosynthesis could be a promising drug target in not just T. brucei but in other eukaryotic pathogens.
引用
收藏
页码:19987 / 19998
页数:12
相关论文
共 50 条
  • [1] Inhibition of eukaryotic translation initiation factor 5A (eIF5A) hypusination impairs melanoma growth
    Jasiulionis, Miriam G.
    Luchessi, Augusto D.
    Moreira, Andreia G.
    Souza, Pedro P. C.
    Suenaga, Ana P. M.
    Correa, Mariangeta
    Costa, Carlos A. S.
    Curi, Rui
    Costa-Neto, Claudio M.
    CELL BIOCHEMISTRY AND FUNCTION, 2007, 25 (01) : 109 - 114
  • [2] Insights on eukaryotic translation initiation factor 5A (eIF5A) in the brain and aging
    Luchessi, Augusto D.
    Cambiaghi, Tavane D.
    Alves, Adilson S.
    Parreiras-E-Silva, Lucas T.
    Britto, Luiz R. G.
    Costa-Neto, Claudio M.
    Curi, Rui
    BRAIN RESEARCH, 2008, 1228 : 6 - 13
  • [3] Eukaryotic translation initiation factor 5A (eIF5A) is essential for HIF-1α activation in hypoxia
    Tariq, Mohammad
    Ito, Akihiro
    Ishfaq, Muhammad
    Bradshaw, Elliot
    Yoshida, Minoru
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 470 (02) : 417 - 424
  • [4] Acetylation regulates subcellular localization of eukaryotic translation initiation factor 5A (eIF5A)
    Ishfaq, Muhammad
    Maeta, Kazuhiro
    Maeda, Satoko
    Natsume, Toru
    Ito, Akihiro
    Yoshida, Minoru
    FEBS LETTERS, 2012, 586 (19) : 3236 - 3241
  • [5] Inhibition of cell growth through inactivation of eukaryotic translation initiation factor 5A (eIF5A) by deoxyspergualin
    Nishimura, K
    Ohki, Y
    Fukuchi-Shimogori, T
    Sakata, K
    Saiga, K
    Beppu, T
    Shirahata, A
    Kashiwagi, K
    Igarashi, K
    BIOCHEMICAL JOURNAL, 2002, 363 : 761 - 768
  • [6] Inhibition of Eukaryotic Translation Initiation Factor 5A (eIF5A) Hypusination Suppress p53 Translation and Alters the Association of eIF5A to the Ribosomes
    Martella, Marianna
    Catalanotto, Caterina
    Talora, Claudio
    La Teana, Anna
    Londei, Paola
    Benelli, Dario
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) : 1 - 19
  • [7] Overexpression of eukaryotic initiation factor 5A (eIF5A) affects susceptibility to benznidazole in Trypanosoma cruzi populations
    Moreira, Douglas de Souza
    Duarte, Ana Paula
    Mirsky Pais, Fabiano Sviatopolk
    da Silva-Pereira, Rosiane Aparecida
    Romanha, Alvaro Jose
    Schenkman, Sergio
    Fonseca Murta, Silvane Maria
    MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2018, 113 (09):
  • [8] Evidences of a Role for Eukaryotic Translation Initiation Factor 5A (eIF5A) in Mouse Embryogenesis and Cell Differentiation
    Parreiras-e-Silva, Lucas T.
    Luchessi, Augusto D.
    Reis, Rosana I.
    Oliver, Constance
    Jamur, Maria C.
    Ramos, Ricardo G. P.
    Oliveira, Eduardo B.
    Curi, Rui
    Costa-Neto, Claudio M.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2010, 225 (02) : 500 - 505
  • [9] Prognostic significance and therapeutic potential of eukaryotic translation initiation factor 5A (eIF5A) in hepatocellular carcinoma
    Lee, Nikki P.
    Tsang, Felice H.
    Shek, Felix H.
    Mao, Mao
    Dai, Hongyue
    Zhang, Chunsheng
    Dong, Suisui
    Guan, Xin-yuan
    Poon, Ronnie T. P.
    Luk, John M.
    INTERNATIONAL JOURNAL OF CANCER, 2010, 127 (04) : 968 - 976
  • [10] Specificity of the deoxyhypusine hydroxylase-eukaryotic translation initiation factor (eIF5A) interaction - Identification of amino acid residues of the enzyme required for binding of its substrate, deoxyhypusine-containing eIF5A
    Kang, Kee Ryeon
    Kim, Yeon Sook
    Wolff, Edith C.
    Park, Myung Hee
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (11) : 8300 - 8308